Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating infancy hemangioma

A technology of hemangioma and composition, applied in the field of traditional Chinese medicine, can solve the problems of skin allergy, long curing time and low curing rate, etc.

Inactive Publication Date: 2017-05-10
宋华
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In summary, the existing traditional Chinese medicine composition has made some progress in the treatment of hemangioma, but there are some problems such as low cure rate, long cure time, strong irritation to normal skin, skin allergies, scars or scars left after healing, etc. Shortcomings seriously affect the physical and mental growth of infants and young children

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048]Example 1: Measure centipede, scorpion, toad venom, tortoise shell, cassia seed, Yuanhu, mandala flower, blood dried fruit, Corydalis corydalis, Sanleng, Nansha ginseng, Gansong, Chuanbei, Yuzhu, bezoar, and bear bile according to the formula , calamus, vitices, cassia twigs, cinnamon, lark, dodder, hippocampus decoction pieces, crushed into drug powder and passed through a 50-mesh sieve, soaked the sieved drug powder in deionized water at 45°C for half an hour, and then wiped it with gauze Filter the dregs of the medicine, wrap the dregs with the gauze and tie the mouth, put it into a pot for decoction, add 2500g of water, decoct for 3 hours at normal temperature and pressure, remove the medicine bag, add sesame oil and honey and decoct for 15 minutes in the pot Finally, add borneol, menthol, reconcile into ointment and obtain ointment A.

Embodiment 2

[0050] (1) Monarch drug decoction: Take centipede, scorpion, toad, and tortoise shell decoction pieces twice as much as the formula, crush them into powder and pass through a 100-mesh sieve, soak the sieved powder in deionized water at 45°C for 1 hour Finally, filter the medicinal mud with a double-layer non-woven fabric, wrap the medicinal mud with the double-layer non-woven fabric and tie the mouth, put it into an automatic decoction machine, add 200g of water, and decoct at a working pressure of 170kPa and a temperature of 130°C. Boil for 1 hour, remove the non-woven medicine bag, add 10g of honey to the medicinal liquid, continue to decoct for 2 hours under normal temperature and pressure difference, until the medicinal liquid is concentrated into a paste, and the monarch medicine ointment is obtained;

[0051] (2) Decoction of ministerial medicine: Take the cassia seed, Yuanhu, mandala flower, blood dried fruit, Corydalis Corydalis, and Sanleng decoction pieces in the pres...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating infancy hemangioma. The pharmaceutical composition is prepared from the following crude drugs: centipede, scorpion, venenum bufonis, tortoise shell, semen cassiae, rhizoma corydalis, flos daturae metelis, sangusis draconis, rhizoma corydalis, rhizoma sparganii, radix adenophorae, radix et rhizoma nardostachyos, bulbus fritillariae cirrhosae, radix polygonati officinalis, calculus bovis, bear gall, rhizoma acori graminei, fructus viticis, ramulus cinnamomi, cortex cinnamomi, radix marsdeniae longipedis, semen cuscutae and sea horse, wherein the centipede, the scorpion, the venenum bufonis and the tortoise shell are used as monarch drugs, the semen cassiae, the rhizoma corydalis, the flos daturae metelis, the sangusis draconis, the rhizoma corydalis and the rhizoma sparganii are used as ministerial drugs, the radix adenophorae, the radix et rhizoma nardostachyos, the bulbus fritillariae cirrhosae, the radix polygonati officinalis, the calculus bovis and the bear gall are used as adjuvant drugs, and the rhizoma acori graminei, the fructus viticis, the ramulus cinnamomi, the cortex cinnamomi, the radix marsdeniae longipedis, the semen cuscutae and the sea horse are used as messenger drugs. The components of the pharmaceutical composition cooperate with each other, and the pharmaceutical composition has the effects of cooling blood and removing blood stasis as well as dissipating blood stasis and stopping pain. When being used for treating the infancy hemangioma, the pharmaceutical composition is high in effective rate and short in course of treatment, does not leave a scar, and does not easily cause relapse; furthermore, the components of the pharmaceutical composition are easy to obtain, safe and reliable, and free from skin irritation and toxic and side effects, so that the pharmaceutical composition is easy to popularize and apply and has obvious economic and social benefits.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, relates to a kind of medicine for external use on tumors, in particular to a medicine composition for treating hemangioma in children. Background technique [0002] Hemangioma refers to a benign tumor occurring in vascular tissue, which is formed due to the hamstring and tumor-like hyperplasia of vascular tissue. There are two types, of which primary accounts for 75% and secondary accounts for about 25%. Most of the secondary ones appear in infancy, and a few are found in adulthood. The etiology is still unclear. Primary, that is, congenital viviparous is formed by the proliferation of human embryonic vascular network, which is present at birth, and may be asymptomatic when the hemangioma is small. Hemangiomas can occur in various parts of the body, such as the face and exposed parts of the extremities, which can affect the appearance. It oppresses and destroys the functio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/902A61P35/00A61K35/60A61K35/413A61K35/648A61K35/646A61K35/65A61K35/586
CPCA61K35/413A61K35/586A61K35/60A61K35/646A61K35/648A61K35/65A61K36/27A61K36/342A61K36/39A61K36/43A61K36/482A61K36/54A61K36/66A61K36/81A61K36/84A61K36/85A61K36/888A61K36/889A61K36/896A61K36/8966A61K36/8969A61K36/902A61K2236/331A61K2236/39A61K2300/00
Inventor 宋华韩灵敏
Owner 宋华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com